Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Accumulated Depreciation & Amortization: 2013-2018

  • Soleno Therapeutics' Accumulated Depreciation & Amortization rose 25.68% to $93,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $429,279, marking a year-over-year decrease of 13.66%. This contributed to the annual value of $93,000 for FY2018, which is 25.68% up from last year.
  • Per Soleno Therapeutics' latest filing, its Accumulated Depreciation & Amortization stood at $93,000 for Q4 2018, which was up 25.68% from $74,000 recorded in Q4 2017.
  • Soleno Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $211,850 for Q4 2015, and its period low was $50,429 during Q4 2016.
  • Its 3-year average for Accumulated Depreciation & Amortization is $72,476, with a median of $74,000 in 2017.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first slumped by 76.20% in 2016, then spiked by 46.74% in 2017.
  • Quarterly analysis of 5 years shows Soleno Therapeutics' Accumulated Depreciation & Amortization stood at $160,912 in 2014, then skyrocketed by 31.66% to $211,850 in 2015, then slumped by 76.20% to $50,429 in 2016, then skyrocketed by 46.74% to $74,000 in 2017, then increased by 25.68% to $93,000 in 2018.
  • Its Accumulated Depreciation & Amortization was $93,000 in Q4 2018, compared to $74,000 in Q4 2017 and $50,429 in Q4 2016.